MEOBF
Price
$0.96
Change
-$0.00 (-0.00%)
Updated
Jun 23 closing price
Capitalization
1.4B
55 days until earnings call
MMIRF
Price
$0.05
Change
-$0.00 (-0.00%)
Updated
Jun 18 closing price
Capitalization
38.68M
Interact to see
Advertisement

MEOBF vs MMIRF

Header iconMEOBF vs MMIRF Comparison
Open Charts MEOBF vs MMIRFBanner chart's image
Mesoblast
Price$0.96
Change-$0.00 (-0.00%)
Volume$1K
Capitalization1.4B
Medmira
Price$0.05
Change-$0.00 (-0.00%)
Volume$31.5K
Capitalization38.68M
MEOBF vs MMIRF Comparison Chart in %
Loading...
MEOBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MMIRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MEOBF vs. MMIRF commentary
Jul 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MEOBF is a Buy and MMIRF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 03, 2025
Stock price -- (MEOBF: $0.96 vs. MMIRF: $0.05)
Brand notoriety: MEOBF and MMIRF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MEOBF: 79% vs. MMIRF: 388%
Market capitalization -- MEOBF: $1.4B vs. MMIRF: $38.68M
MEOBF [@Biotechnology] is valued at $1.4B. MMIRF’s [@Biotechnology] market capitalization is $38.68M. The market cap for tickers in the [@Biotechnology] industry ranges from $307.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MEOBF’s FA Score shows that 0 FA rating(s) are green whileMMIRF’s FA Score has 1 green FA rating(s).

  • MEOBF’s FA Score: 0 green, 5 red.
  • MMIRF’s FA Score: 1 green, 4 red.
According to our system of comparison, MMIRF is a better buy in the long-term than MEOBF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MEOBF’s TA Score shows that 4 TA indicator(s) are bullish while MMIRF’s TA Score has 3 bullish TA indicator(s).

  • MEOBF’s TA Score: 4 bullish, 3 bearish.
  • MMIRF’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, MEOBF is a better buy in the short-term than MMIRF.

Price Growth

MEOBF (@Biotechnology) experienced а 0.00% price change this week, while MMIRF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.20%. For the same industry, the average monthly price growth was +33.12%, and the average quarterly price growth was +1.51%.

Reported Earning Dates

MEOBF is expected to report earnings on Aug 27, 2025.

Industries' Descriptions

@Biotechnology (+1.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MEOBF($1.4B) has a higher market cap than MMIRF($38.7M). MMIRF YTD gains are higher at: 312.214 vs. MEOBF (-56.136). MMIRF has higher annual earnings (EBITDA): -3.13M vs. MEOBF (-77.78M). MEOBF has more cash in the bank: 37.7M vs. MMIRF (296K). MMIRF has less debt than MEOBF: MMIRF (9.49M) vs MEOBF (126M). MEOBF has higher revenues than MMIRF: MEOBF (5.67M) vs MMIRF (277K).
MEOBFMMIRFMEOBF / MMIRF
Capitalization1.4B38.7M3,615%
EBITDA-77.78M-3.13M2,482%
Gain YTD-56.136312.214-18%
P/E RatioN/AN/A-
Revenue5.67M277K2,047%
Total Cash37.7M296K12,736%
Total Debt126M9.49M1,328%
FUNDAMENTALS RATINGS
MEOBF vs MMIRF: Fundamental Ratings
MEOBF
MMIRF
OUTLOOK RATING
1..100
3647
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
5
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
95100
PRICE GROWTH RATING
1..100
6534
P/E GROWTH RATING
1..100
59100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MMIRF's Valuation (5) in the null industry is significantly better than the same rating for MEOBF (88). This means that MMIRF’s stock grew significantly faster than MEOBF’s over the last 12 months.

MMIRF's Profit vs Risk Rating (100) in the null industry is in the same range as MEOBF (100). This means that MMIRF’s stock grew similarly to MEOBF’s over the last 12 months.

MEOBF's SMR Rating (95) in the null industry is in the same range as MMIRF (100). This means that MEOBF’s stock grew similarly to MMIRF’s over the last 12 months.

MMIRF's Price Growth Rating (34) in the null industry is in the same range as MEOBF (65). This means that MMIRF’s stock grew similarly to MEOBF’s over the last 12 months.

MEOBF's P/E Growth Rating (59) in the null industry is somewhat better than the same rating for MMIRF (100). This means that MEOBF’s stock grew somewhat faster than MMIRF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MEOBFMMIRF
RSI
ODDS (%)
Bullish Trend 4 days ago
44%
Bearish Trend 4 days ago
67%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
50%
Bearish Trend 4 days ago
69%
Momentum
ODDS (%)
Bullish Trend 4 days ago
50%
Bullish Trend 4 days ago
69%
MACD
ODDS (%)
Bearish Trend 4 days ago
62%
Bearish Trend 4 days ago
59%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
53%
Bullish Trend 4 days ago
58%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
52%
Bullish Trend 4 days ago
61%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
55%
Bearish Trend 4 days ago
75%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
MEOBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MMIRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DEWY2.16N/A
N/A
Dewey Electronics Corp. (The)
SNDVF13.38N/A
N/A
Scandinavian Tob Group AS
SLVRF0.22N/A
-0.59%
Silver One Resources Inc.
HSQVY10.56-0.24
-2.27%
Husqvarna AB
SMECF353.90-9.10
-2.51%
SMC Corp

MEOBF and

Correlation & Price change

A.I.dvisor tells us that MEOBF and RLYB have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MEOBF and RLYB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MEOBF
1D Price
Change %
MEOBF100%
N/A
RLYB - MEOBF
25%
Poorly correlated
+1.62%
ADIL - MEOBF
24%
Poorly correlated
N/A
MMIRF - MEOBF
10%
Poorly correlated
N/A
MLLCF - MEOBF
6%
Poorly correlated
N/A
IPHYF - MEOBF
5%
Poorly correlated
N/A
More

MMIRF and

Correlation & Price change

A.I.dvisor tells us that MMIRF and SGMT have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MMIRF and SGMT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MMIRF
1D Price
Change %
MMIRF100%
N/A
SGMT - MMIRF
32%
Poorly correlated
-3.18%
NWPHF - MMIRF
29%
Poorly correlated
N/A
VTYX - MMIRF
26%
Poorly correlated
-8.74%
AXSM - MMIRF
21%
Poorly correlated
+1.00%
DNTH - MMIRF
21%
Poorly correlated
+5.67%
More